TY - STD TI - Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36:277–85. ID - ref1 ER - TY - JOUR AU - Vos, H. I. AU - Coenen, M. J. AU - Guchelaar, H. J. AU - Te Loo, D. M. PY - 2016 DA - 2016// TI - The role of pharmacogenetics in the treatment of osteosarcoma JO - Drug Discov Today VL - 21 UR - https://doi.org/10.1016/j.drudis.2016.06.022 DO - 10.1016/j.drudis.2016.06.022 ID - Vos2016 ER - TY - JOUR AU - Garami, M. AU - Schuler, D. AU - Jakab, Z. PY - 2014 DA - 2014// TI - Az Országos Gyermektumor Regiszter jelentősége a gyermekonkológiai ellátásban Importance of the National Childhood Cancer Registry in the field of paediatric oncology care JO - Orv Hetil VL - 155 UR - https://doi.org/10.1556/OH.2014.29918 DO - 10.1556/OH.2014.29918 ID - Garami2014 ER - TY - JOUR AU - Pui, C. AU - Evans, W. PY - 2006 DA - 2006// TI - Treatment of acute lymphoblastic leukemia JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMra052603 DO - 10.1056/NEJMra052603 ID - Pui2006 ER - TY - JOUR AU - Carroll, W. L. AU - Raetz, E. A. PY - 2012 DA - 2012// TI - Clinical and laboratory biology of childhood acute lymphoblastic leukemia JO - J Pediatr VL - 160 UR - https://doi.org/10.1016/j.jpeds.2011.08.006 DO - 10.1016/j.jpeds.2011.08.006 ID - Carroll2012 ER - TY - JOUR AU - Gaynon, P. S. AU - Angiolillo, A. L. AU - Carroll, W. L. AU - Nachman, J. B. AU - Trigg, M. E. AU - Sather, H. N. PY - 2010 DA - 2010// TI - Long Term Results of the Children’s Cancer Group Studies for Childhood Acute Lymphoblastic Leukemia 1983–2002: a Children’s Oncology Group Report NIH Public Access JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.262 DO - 10.1038/leu.2009.262 ID - Gaynon2010 ER - TY - JOUR AU - Fulbright, J. M. AU - Raman, S. AU - McClellan, W. S. AU - August, K. J. PY - 2011 DA - 2011// TI - Late effects of childhood leukemia therapy JO - Curr Hematol Malig Rep VL - 6 UR - https://doi.org/10.1007/s11899-011-0094-x DO - 10.1007/s11899-011-0094-x ID - Fulbright2011 ER - TY - JOUR AU - Ansari, M. AU - Sauty, G. AU - Labuda, M. AU - Gagné, V. AU - Rousseau, J. AU - Moghrabi, A. PY - 2012 DA - 2012// TI - Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia JO - Pharmacogenomics J VL - 1217 UR - https://doi.org/10.1038/tpj.2011.17 DO - 10.1038/tpj.2011.17 ID - Ansari2012 ER - TY - JOUR AU - Lopez-Lopez, E. AU - Ballesteros, J. AU - Piñan, M. A. AU - Sanchez de Toledo, J. AU - Garcia de Andoin, N. AU - Garcia-Miguel, P. PY - 2013 DA - 2013// TI - Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia JO - Pharmacogenet Genomics VL - 23 UR - https://doi.org/10.1097/FPC.0b013e32835c3b24 DO - 10.1097/FPC.0b013e32835c3b24 ID - Lopez-Lopez2013 ER - TY - STD TI - Robison LL. Late effec ts of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age. Hematol Am Soc Hematol Educ Program. 2011;2011:238–42 ID - ref10 ER - TY - JOUR AU - Sundberg, K. K. AU - Doukkali, E. AU - Lampic, C. AU - Eriksson, L. E. AU - Arvidson, J. AU - Wettergren, L. PY - 2010 DA - 2010// TI - Long-term survivors of childhood Cancer report quality of life and health status in parity with a comparison group JO - Pediatr Blood Cancer VL - 55 UR - https://doi.org/10.1002/pbc.22492 DO - 10.1002/pbc.22492 ID - Sundberg2010 ER - TY - JOUR AU - Kremer, L. C. AU - van der Pal, H. J. AU - Offringa, M. AU - van Dalen, E. C. AU - Voûte, P. A. PY - 2002 DA - 2002// TI - Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf167 DO - 10.1093/annonc/mdf167 ID - Kremer2002 ER - TY - JOUR AU - Shelmerdine, S. C. AU - Chavhan, G. B. AU - Babyn, P. S. AU - Nathan, P. C. AU - Kaste, S. C. PY - 2017 DA - 2017// TI - Imaging of acute and subacute toxicities of cancer therapy in children JO - Pediatr Radiol VL - 47 UR - https://doi.org/10.1007/s00247-016-3708-6 DO - 10.1007/s00247-016-3708-6 ID - Shelmerdine2017 ER - TY - JOUR AU - Billett, A. PY - 2016 DA - 2016// TI - How should pediatric Cancer be included in the Cancer moonshot? JO - Oncol Times VL - 38 UR - https://doi.org/10.1097/01.COT.0000502636.99578.21 DO - 10.1097/01.COT.0000502636.99578.21 ID - Billett2016 ER - TY - JOUR AU - Armstrong, G. T. AU - Kawashima, T. AU - Leisenring, W. AU - Stratton, K. AU - Stovall, M. AU - Hudson, M. M. PY - 2014 DA - 2014// TI - Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.51.1055 DO - 10.1200/JCO.2013.51.1055 ID - Armstrong2014 ER - TY - STD TI - Marder J. Childhood’s Cures Haunted By Adulthood’s ‘Late Effects’. Science. 2010;328:1474–5. ID - ref16 ER - TY - JOUR AU - Armstrong, G. T. AU - Liu, Q. AU - Yasui, Y. AU - Neglia, J. P. AU - Leisenring, W. AU - Robison, L. L. PY - 2009 DA - 2009// TI - Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.21.1425 DO - 10.1200/JCO.2008.21.1425 ID - Armstrong2009 ER - TY - JOUR AU - Lipshultz, S. E. AU - Alvarez, J. A. AU - Scully, R. E. PY - 2008 DA - 2008// TI - Anthracycline associated cardiotoxicity in survivors of childhood cancer JO - Heart VL - 94 UR - https://doi.org/10.1136/hrt.2007.136093 DO - 10.1136/hrt.2007.136093 ID - Lipshultz2008 ER - TY - JOUR AU - Vandecruys, E. AU - Mondelaers, V. AU - De Wolf, D. AU - Benoit, Y. AU - Suys, B. PY - 2012 DA - 2012// TI - Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood JO - J Cancer Surviv VL - 6 UR - https://doi.org/10.1007/s11764-011-0186-6 DO - 10.1007/s11764-011-0186-6 ID - Vandecruys2012 ER - TY - JOUR AU - Ruggiero, A. AU - De Rosa, G. AU - Rizzo, D. AU - Leo, A. AU - Maurizi, P. AU - De Nisco, A. PY - 2013 DA - 2013// TI - Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia JO - Int J Clin Oncol VL - 18 UR - https://doi.org/10.1007/s10147-012-0458-9 DO - 10.1007/s10147-012-0458-9 ID - Ruggiero2013 ER - TY - JOUR AU - Bayraktar, S. AU - Glück, S. PY - 2012 DA - 2012// TI - Systemic therapy options in BRCA mutation-associated breast cancer JO - Breast Cancer Res Treat VL - 135 UR - https://doi.org/10.1007/s10549-012-2158-6 DO - 10.1007/s10549-012-2158-6 ID - Bayraktar2012 ER - TY - JOUR AU - Mikhail, M. AU - Mekhail, Y. AU - Mekhail, T. PY - 2012 DA - 2012// TI - Thymic neoplasms: a clinical update JO - Curr Oncol Rep VL - 14 UR - https://doi.org/10.1007/s11912-012-0246-8 DO - 10.1007/s11912-012-0246-8 ID - Mikhail2012 ER - TY - JOUR AU - Sokol, L. AU - Naghashpour, M. AU - Frank Glass, L. PY - 2012 DA - 2012// TI - Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management JO - Cancer Control VL - 19 UR - https://doi.org/10.1177/107327481201900308 DO - 10.1177/107327481201900308 ID - Sokol2012 ER - TY - JOUR AU - dos Santos, L. V. AU - Lima, J. AU - Lima, C. S. AU - Sasse, E. C. AU - Sasse, A. D. PY - 2012 DA - 2012// TI - Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-288 DO - 10.1186/1471-2407-12-288 ID - dos Santos2012 ER - TY - JOUR AU - Ray-Coquard, I. AU - Le Cesne, A. PY - 2012 DA - 2012// TI - A role for maintenance therapy in managing sarcoma JO - Cancer Treat Rev VL - 38 UR - https://doi.org/10.1016/j.ctrv.2011.07.003 DO - 10.1016/j.ctrv.2011.07.003 ID - Ray-Coquard2012 ER - TY - JOUR AU - Fulbright, J. M. PY - 2011 DA - 2011// TI - Review of cardiotoxicity in pediatric Cancer patients: during and after therapy JO - Cardiol Res Pract VL - 2011 UR - https://doi.org/10.4061/2011/942090 DO - 10.4061/2011/942090 ID - Fulbright2011 ER - TY - JOUR AU - Mulrooney, D. A. AU - Yeazel, M. W. AU - Kawashima, T. AU - Mertens, A. C. AU - Mitby, P. AU - Stovall, M. PY - 2009 DA - 2009// TI - Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood Cancer survivor study cohort JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b4606 DO - 10.1136/bmj.b4606 ID - Mulrooney2009 ER - TY - JOUR AU - Yeh, E. T. AU - Bickford, C. L. PY - 2009 DA - 2009// TI - Cardiovascular complications of Cancer therapy JO - J Am Coll Cardiol VL - 53 UR - https://doi.org/10.1016/j.jacc.2009.02.050 DO - 10.1016/j.jacc.2009.02.050 ID - Yeh2009 ER - TY - JOUR AU - Viale, P. H. AU - Yamamoto, D. S. PY - 2008 DA - 2008// TI - Cardiovascular toxicity associated with cancer treatment JO - Clin J Oncol Nurs VL - 12 UR - https://doi.org/10.1188/08.CJON.627-638 DO - 10.1188/08.CJON.627-638 ID - Viale2008 ER - TY - STD TI - Iarussi D, Indolfi P, Casale F, Martino V, Di Tullio MT, Calabrò R. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Pediatr Drugs. 2005;7:67–76. ID - ref30 ER - TY - JOUR AU - Mordente, A. AU - Meucci, E. AU - Silvestrini, A. AU - Martorana, G. E. AU - Giardina, B. PY - 2009 DA - 2009// TI - New developments in anthracycline-induced cardiotoxicity JO - Curr Med Chem VL - 16 UR - https://doi.org/10.2174/092986709788186228 DO - 10.2174/092986709788186228 ID - Mordente2009 ER - TY - JOUR AU - Menna, P. AU - Recalcati, S. AU - Cairo, G. AU - Minotti, G. PY - 2007 DA - 2007// TI - An introduction to the metabolic determinants of anthracycline cardiotoxicity JO - Cardiovasc Toxicol VL - 7 UR - https://doi.org/10.1007/s12012-007-0011-7 DO - 10.1007/s12012-007-0011-7 ID - Menna2007 ER - TY - JOUR AU - Lipshultz, S. E. AU - Adams, M. J. PY - 2010 DA - 2010// TI - Cardiotoxicity after childhood cancer: beginning with the end in mind JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.5751 DO - 10.1200/JCO.2009.26.5751 ID - Lipshultz2010 ER - TY - JOUR AU - Hershman, D. L. AU - Neugut, A. I. PY - 2008 DA - 2008// TI - Anthracycline cardiotoxicity: one size does not fit all! JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn241 DO - 10.1093/jnci/djn241 ID - Hershman2008 ER - TY - JOUR AU - Mody, R. AU - Li, S. AU - Dover, D. C. AU - Sallan, S. AU - Leisenring, W. AU - Oeffinger, K. C. PY - 2008 DA - 2008// TI - Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the childhood Cancer survivor study JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-10-117150 DO - 10.1182/blood-2007-10-117150 ID - Mody2008 ER - TY - JOUR AU - Boyett, J. AU - Cheng, C. AU - Pei, D. AU - Pui, C. PY - 2009 DA - 2009// TI - Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis JO - Br J Haematol VL - 145 UR - https://doi.org/10.1111/j.1365-2141.2009.07624.x DO - 10.1111/j.1365-2141.2009.07624.x ID - Boyett2009 ER - TY - JOUR AU - Visscher, H. AU - Ross, C. J. AU - Rassekh, S. R. AU - Barhdadi, A. AU - Dubé, M. P. AU - Al-Saloos, H. PY - 2012 DA - 2012// TI - Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2010.34.3467 DO - 10.1200/JCO.2010.34.3467 ID - Visscher2012 ER - TY - JOUR AU - Wojnowski, L. AU - Kulle, B. AU - Schirmer, M. AU - Schlüter, G. AU - Schmidt, A. AU - Rosenberger, A. PY - 2005 DA - 2005// TI - NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.105.576850 DO - 10.1161/CIRCULATIONAHA.105.576850 ID - Wojnowski2005 ER - TY - JOUR AU - Visscher, H. AU - Amstutz, U. AU - Sistonen, J. AU - Ross, C. J. AU - Hayden, M. R. AU - Carleton, B. C. PY - 2011 DA - 2011// TI - Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics JO - J Cardiovasc Pharmacol VL - 58 UR - https://doi.org/10.1097/FJC.0b013e3182163b82 DO - 10.1097/FJC.0b013e3182163b82 ID - Visscher2011 ER - TY - JOUR AU - Bains, O. S. AU - Takahashi, R. H. AU - Pfeifer, T. A. AU - Grigliatti, T. A. AU - Reid, R. E. AU - Riggs, K. W. PY - 2008 DA - 2008// TI - Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin JO - Drug Metab Dispos VL - 36 UR - https://doi.org/10.1124/dmd.107.018895 DO - 10.1124/dmd.107.018895 ID - Bains2008 ER - TY - JOUR AU - Bains, O. S. AU - Karkling, M. J. AU - Grigliatti, T. A. AU - Reid, R. E. AU - Riggs, K. W. PY - 2009 DA - 2009// TI - Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of Daunorubicin and doxorubicin JO - Drug Metab Dispos VL - 37 UR - https://doi.org/10.1124/dmd.108.024711 DO - 10.1124/dmd.108.024711 ID - Bains2009 ER - TY - JOUR AU - Lal, S. AU - Sandanaraj, E. AU - Wong, Z. W. AU - Ang, P. C. AU - Wong, N. S. AU - Lee, E. J. PY - 2008 DA - 2008// TI - CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients JO - Cancer Sci VL - 99 UR - https://doi.org/10.1111/j.1349-7006.2008.00744.x DO - 10.1111/j.1349-7006.2008.00744.x ID - Lal2008 ER - TY - JOUR AU - Lal, S. AU - Wong, Z. W. AU - Sandanaraj, E. AU - Xiang, X. AU - Ang, P. C. AU - Lee, E. J. PY - 2008 DA - 2008// TI - Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients JO - Cancer Sci VL - 99 UR - https://doi.org/10.1111/j.1349-7006.2008.00744.x DO - 10.1111/j.1349-7006.2008.00744.x ID - Lal2008 ER - TY - JOUR AU - Bhatia, S. PY - 2011 DA - 2011// TI - Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors JO - Cancer Epidemiol Biomark Prev VL - 20 UR - https://doi.org/10.1158/1055-9965.EPI-11-0659 DO - 10.1158/1055-9965.EPI-11-0659 ID - Bhatia2011 ER - TY - JOUR AU - Lal, S. AU - Mahajan, A. AU - Chen, W. N. AU - Chowbay, B. PY - 2010 DA - 2010// TI - Pharmacogenetics of target genes across doxorubicin disposition pathway: a review JO - Curr Drug Metab VL - 11 UR - https://doi.org/10.2174/138920010791110890 DO - 10.2174/138920010791110890 ID - Lal2010 ER - TY - JOUR AU - Thorn, C. AU - Oshiro, C. AU - Marsh, S. AU - Hernandez-Boussard, T. AU - McLeod, H. AU - Klein, T. PY - 2011 DA - 2011// TI - Doxorubicin pathways:pharmacodynamics and adverse effects JO - Pharmacogenet Genomics VL - 21 UR - https://doi.org/10.1097/FPC.0b013e32833ffb56 DO - 10.1097/FPC.0b013e32833ffb56 ID - Thorn2011 ER - TY - JOUR AU - Rajić, V. AU - Aplenc, R. AU - Debeljak, M. AU - Prestor, V. V. AU - Karas-Kuzelicki, N. AU - Mlinaric-Rascan, I. PY - 2009 DA - 2009// TI - Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood JO - Leuk Lymphoma VL - 50 UR - https://doi.org/10.1080/10428190903177212 DO - 10.1080/10428190903177212 ID - Rajić2009 ER - TY - STD TI - Sági JC, Kutszegi N, Kelemen A, Fodor LE, Gézsi A, Kovács GT, et al. Pharmacogenetics of anthracyclines. Pharmacogenomics. 2016;17:1075–87. ID - ref48 ER - TY - STD TI - Aminkeng F, Ross CJ, Rassekh SR, Hwang S, Rieder MJ, Bhavsar AP, et al. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol. 2016;82:683–95. ID - ref49 ER - TY - JOUR AU - Leong, S. L. AU - Chaiyakunapruk, N. AU - Lee, S. W. PY - 2017 DA - 2017// TI - Candidate Gene Association studies of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-00075-1 DO - 10.1038/s41598-017-00075-1 ID - Leong2017 ER - TY - JOUR AU - Erdilyi, D. J. AU - Kámory, E. AU - Csókay, B. AU - Andrikovics, H. AU - Tordai, A. AU - Kiss, C. PY - 2008 DA - 2008// TI - Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy JO - Pharmacogenomics J. VL - 8 UR - https://doi.org/10.1038/sj.tpj.6500480 DO - 10.1038/sj.tpj.6500480 ID - Erdilyi2008 ER - TY - JOUR AU - Hegyi, M. AU - Csordas, K. AU - Eipel, O. AU - Csagoly, E. AU - Erdelyi, D. J. AU - Semsei, A. F. PY - 2017 DA - 2017// TI - Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.11543 DO - 10.18632/oncotarget.11543 ID - Hegyi2017 ER - TY - JOUR AU - Aminkeng, F. AU - Bhavsar, A. P. AU - Visscher, H. AU - Rassekh, S. R. AU - Li, Y. AU - Lee, J. W. PY - 2015 DA - 2015// TI - A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer JO - Nat Genet VL - 47 UR - https://doi.org/10.1038/ng.3374 DO - 10.1038/ng.3374 ID - Aminkeng2015 ER - TY - JOUR AU - Wang, X. AU - Liu, W. AU - Sun, C. L. AU - Armenian, S. H. AU - Hakonarson, H. AU - Hageman, L. PY - 2014 DA - 2014// TI - Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the Children’s oncology group JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.50.3557 DO - 10.1200/JCO.2013.50.3557 ID - Wang2014 ER - TY - JOUR AU - Wheeler, H. E. AU - Gamazon, E. R. AU - Stark, A. L. AU - Donnell, P. H. O. AU - Lidija, K. AU - Huang, R. S. PY - 2013 DA - 2013// TI - Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations JO - Pharmacogenomics J. VL - 13 UR - https://doi.org/10.1038/tpj.2011.38 DO - 10.1038/tpj.2011.38 ID - Wheeler2013 ER - TY - STD TI - HapMap database. p. http://hapmap.ncbi.nlm.nih.gov/ Accessed 14/11/16. UR - http://hapmap.ncbi.nlm.nih.gov/ ID - ref56 ER - TY - JOUR AU - Banlaki, Z. AU - Elek, Z. AU - Nanasi, T. AU - Szekely, A. AU - Nemoda, Z. AU - Sasvari-Szekely, M. PY - 2015 DA - 2015// TI - Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0117792 DO - 10.1371/journal.pone.0117792 ID - Banlaki2015 ER - TY - STD TI - Tests for deviation from Hardy-Weinberg equilibrium p. https://ihg.gsf.de/cgi-bin/hw/hwa1.pl. UR - https://ihg.gsf.de/cgi-bin/hw/hwa1.pl ID - ref58 ER - TY - STD TI - B enjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300. ID - ref59 ER - TY - JOUR AU - Storey, J. D. PY - 2002 DA - 2002// TI - A direct approach to false discovery rates JO - J R Stat Soc VL - 64 UR - https://doi.org/10.1111/1467-9868.00346 DO - 10.1111/1467-9868.00346 ID - Storey2002 ER - TY - STD TI - Haploview 4.1 software. p. http://www.broad.mit.edu/mpg/haploview/. UR - http://www.broad.mit.edu/mpg/haploview/ ID - ref61 ER - TY - STD TI - Lautner-Csorba O, Gézsi A, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, et al. Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. PLoS One. 2013;8:e69843. ID - ref62 ER - TY - JOUR AU - Sissung, T. M. AU - Baum, C. E. AU - Kirkland, C. T. AU - Gao, R. AU - Gardner, E. R. AU - Figg, W. D. PY - 2010 DA - 2010// TI - Pharmacogenetics of membrane transporters: an update on current approaches JO - Mol Biotechnol VL - 44 UR - https://doi.org/10.1007/s12033-009-9220-6 DO - 10.1007/s12033-009-9220-6 ID - Sissung2010 ER - TY - JOUR AU - Vulsteke, C. AU - Pfeil, A. M. AU - Maggen, C. AU - Schwenkglenks, M. AU - Pettengell, R. AU - Szucs, T. D. PY - 2015 DA - 2015// TI - Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients JO - Breast Cancer Res Treat VL - 152 UR - https://doi.org/10.1007/s10549-015-3437-9 DO - 10.1007/s10549-015-3437-9 ID - Vulsteke2015 ER - TY - JOUR AU - Marsh, S. AU - Hoskins, J. M. PY - 2011 DA - 2011// TI - Irinotecan pharmacogenomics JO - Pharmacogenomics VL - 11 UR - https://doi.org/10.2217/pgs.10.95 DO - 10.2217/pgs.10.95 ID - Marsh2011 ER - TY - JOUR AU - Qu, J. AU - Zhou, B. T. AU - Yin, J. Y. AU - Xu, X. J. AU - Zhao, Y. C. AU - Lei, G. H. PY - 2012 DA - 2012// TI - ABCC2 polymorphisms and haplotype are associated with drug resistance in chinese epileptic patients JO - CNS Neurosci Ther VL - 18 UR - https://doi.org/10.1111/j.1755-5949.2012.00336.x DO - 10.1111/j.1755-5949.2012.00336.x ID - Qu2012 ER - TY - JOUR AU - Sun, N. AU - Sun, X. AU - Chen, B. AU - Cheng, H. AU - Feng, J. AU - Cheng, L. PY - 2010 DA - 2010// TI - MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer JO - Cancer Chemother Pharmacol VL - 65 UR - https://doi.org/10.1007/s00280-009-1046-1 DO - 10.1007/s00280-009-1046-1 ID - Sun2010 ER - TY - JOUR AU - Andersen, V. AU - Vogel, L. K. AU - Kopp, T. I. AU - Sæbø, M. AU - Nonboe, A. W. AU - Hamfjord, J. PY - 2015 DA - 2015// TI - High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119255 DO - 10.1371/journal.pone.0119255 ID - Andersen2015 ER - TY - JOUR AU - Hattinger, C. M. AU - Biason, P. AU - Iacoboni, E. AU - Gagno, S. AU - Fanelli, M. AU - Tavanti, E. PY - 2016 DA - 2016// TI - Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.11486 DO - 10.18632/oncotarget.11486 ID - Hattinger2016 ER - TY - JOUR AU - Zhai, X. AU - Wang, H. AU - Zhu, X. AU - Miao, H. AU - Qian, X. AU - Li, J. PY - 2012 DA - 2012// TI - Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia JO - Arch Med Sci VL - 8 UR - https://doi.org/10.5114/aoms.2012.30290 DO - 10.5114/aoms.2012.30290 ID - Zhai2012 ER - TY - JOUR AU - Armenian, S. H. AU - Ding, Y. AU - Mills, G. AU - Sun, C. AU - Venkataraman, K. AU - Wong, F. L. PY - 2013 DA - 2013// TI - Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation JO - Br J Haematol VL - 163 ID - Armenian2013 ER - TY - JOUR AU - Niemi, M. AU - Arnold, K. A. AU - Backman, J. T. AU - Pasanen, M. K. AU - Gödtel-Armbrust, U. AU - Wojnowski, L. PY - 2006 DA - 2006// TI - Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics JO - Pharmacogenet Genomics VL - 16 UR - https://doi.org/10.1097/01.fpc.0000230422.50962.91 DO - 10.1097/01.fpc.0000230422.50962.91 ID - Niemi2006 ER - TY - JOUR AU - Blanco, J. G. AU - Leisenring, W. M. AU - Gonzalez-Covarrubias, V. M. AU - Kawashima, T. I. AU - Davies, S. M. AU - Relling, M. V. PY - 2008 DA - 2008// TI - Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQ01 in patients who developed anthracycline-related congestive heart failure after childhood cancer JO - Cancer VL - 112 UR - https://doi.org/10.1002/cncr.23534 DO - 10.1002/cncr.23534 ID - Blanco2008 ER - TY - JOUR AU - Krajinovic, M. AU - Labuda, D. AU - Sinnett, D. PY - 2001 DA - 2001// TI - Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome JO - Rev Env Heal VL - 16 ID - Krajinovic2001 ER - TY - JOUR AU - Siegel, D. AU - Yan, C. AU - Ross, D. PY - 2012 DA - 2012// TI - NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones JO - Biochem Pharmacol VL - 83 UR - https://doi.org/10.1016/j.bcp.2011.12.017 DO - 10.1016/j.bcp.2011.12.017 ID - Siegel2012 ER - TY - JOUR AU - Szkandera, J. AU - Absenger, G. AU - Dandachi, N. AU - Regitnig, P. AU - Lax, S. AU - Stotz, M. PY - 2012 DA - 2012// TI - Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer JO - Mol Gen Genomics VL - 287 UR - https://doi.org/10.1007/s00438-012-0715-7 DO - 10.1007/s00438-012-0715-7 ID - Szkandera2012 ER - TY - JOUR AU - Ito, T. AU - Fujio, Y. AU - Takahashi, K. AU - Azuma, J. PY - 2007 DA - 2007// TI - Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M609547200 DO - 10.1074/jbc.M609547200 ID - Ito2007 ER - TY - JOUR AU - Lagoa, R. AU - Gañán, C. AU - López-Sánchez, C. AU - García-Martínez, V. AU - Gutierrez-Merino, C. PY - 2014 DA - 2014// TI - The decrease of NAD(P)H:quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity JO - Biomarkers VL - 19 UR - https://doi.org/10.3109/1354750X.2014.885084 DO - 10.3109/1354750X.2014.885084 ID - Lagoa2014 ER - TY - STD TI - PolymiRTS Database 3.0. p. http://compbio.uthsc.edu/miRSNP/ Accessed 08/03/17. UR - http://compbio.uthsc.edu/miRSNP/ ID - ref79 ER - TY - JOUR AU - Shibayama, Y. AU - Ushinohama, K. AU - Ikeda, R. AU - Yoshikawa, Y. AU - Motoya, T. AU - Takeda, Y. PY - 2006 DA - 2006// TI - Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats JO - Cancer Sci VL - 97 UR - https://doi.org/10.1111/j.1349-7006.2006.00304.x DO - 10.1111/j.1349-7006.2006.00304.x ID - Shibayama2006 ER - TY - JOUR AU - Liu, S. AU - Wang, B. H. AU - Kompa, A. R. AU - Lekawanvijit, S. AU - Krum, H. PY - 2012 DA - 2012// TI - Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate JO - Int J Cardiol VL - 158 UR - https://doi.org/10.1016/j.ijcard.2012.05.022 DO - 10.1016/j.ijcard.2012.05.022 ID - Liu2012 ER - TY - STD TI - Visscher H, Ross CJD, Rassekh SR, Sandor GSS, Caron HN, van Dalen EC, et al. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013;60:1375–81. ID - ref82 ER - TY - JOUR AU - Hertz, D. L. AU - Caram, M. V. AU - Kidwell, K. M. AU - Thibert, J. N. AU - Gersch, C. AU - Seewald, N. J. PY - 2016 DA - 2016// TI - Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines JO - Pharmacogenomics VL - 17 UR - https://doi.org/10.2217/pgs.15.162 DO - 10.2217/pgs.15.162 ID - Hertz2016 ER - TY - JOUR AU - Reichwagen, A. AU - Ziepert, M. AU - Kreuz, M. AU - Gödtel-Armbrust, U. AU - Rixecker, T. AU - Poeschel, V. PY - 2015 DA - 2015// TI - Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma JO - Pharmacogenomics VL - 16 UR - https://doi.org/10.2217/pgs.14.179 DO - 10.2217/pgs.14.179 ID - Reichwagen2015 ER - TY - JOUR AU - Rossi, D. AU - Rasi, S. AU - Franceschetti, S. AU - Capello, D. AU - Castelli, A. AU - De Paoli, L. PY - 2009 DA - 2009// TI - Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 JO - Leukemia VL - 23 UR - https://doi.org/10.1038/leu.2008.398 DO - 10.1038/leu.2008.398 ID - Rossi2009 ER - TY - JOUR AU - Ross, C. AU - Visscher, H. AU - Rassekh, S. AU - Castro-Pastrana, L. AU - Shereck, E. AU - Carleton, B. PY - 2011 DA - 2011// TI - Pharmacogenomics of serious adverse drug reactions in pediatric oncology JO - J Popul Ther Clin Pharmacol VL - 18 ID - Ross2011 ER - TY - JOUR AU - Huang, Z. AU - Wang, J. AU - Qian, J. AU - Li, Y. AU - Xu, Z. AU - Chen, M. PY - 2017 DA - 2017// TI - Effects of cytochrome P450 family 3 subfamily a member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia JO - Mol Med Rep VL - 15 UR - https://doi.org/10.3892/mmr.2017.6470 DO - 10.3892/mmr.2017.6470 ID - Huang2017 ER - TY - JOUR AU - Lipshultz, S. E. AU - Lipsitz, S. R. AU - Mone, S. M. AU - Goorin, A. M. AU - Sallan, S. E. AU - Sanders, S. P. PY - 1995 DA - 1995// TI - Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199506293322602 DO - 10.1056/NEJM199506293322602 ID - Lipshultz1995 ER - TY - JOUR AU - Hequet, O. AU - Le, Q. H. AU - Moullet, I. AU - Pauli, E. AU - Salles, G. AU - Espinouse, D. PY - 2004 DA - 2004// TI - Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.06.033 DO - 10.1200/JCO.2004.06.033 ID - Hequet2004 ER - TY - JOUR AU - Mulrooney, D. A. AU - Armstrong, G. T. AU - Huang, S. AU - Ness, K. K. AU - Ehrhardt, M. J. AU - Joshi, V. M. PY - 2016 DA - 2016// TI - Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study from the St JO - Jude Lifetime Cohort Ann Intern Med VL - 164 UR - https://doi.org/10.7326/M15-0424 DO - 10.7326/M15-0424 ID - Mulrooney2016 ER - TY - JOUR AU - Ventura-Clapier, R. AU - Moulin, M. AU - Piquereau, J. AU - Zurlo, G. AU - Garnier, A. PY - 2016 DA - 2016// TI - Sex differences in anthracycline cardiotoxicity JO - Ital J Gender-Specific Med VL - 2 ID - Ventura-Clapier2016 ER - TY - JOUR AU - Klein, K. AU - Thomas, M. AU - Winter, S. AU - Nussler, A. K. AU - Niemi, M. AU - Schwab, M. PY - 2012 DA - 2012// TI - PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo JO - Clin Pharmacol Ther VL - 91 UR - https://doi.org/10.1038/clpt.2011.336 DO - 10.1038/clpt.2011.336 ID - Klein2012 ER -